Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

Most read article(s)

The Most Read articles represent those articles that are the Most Read in the most recent twelve months.  The list is recalculated once per month for the previous twelve months.

  • Open Access
    Kidney Outcomes in Long COVID
    Benjamin Bowe, Yan Xie, Evan Xu and Ziyad Al-Aly
    JASN November 2021, 32 (11) 2851-2862; DOI: https://doi.org/10.1681/ASN.2021060734
    Add to Selected Citations
  • Open Access
    Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
    Glenn M. Chertow, Priya Vart, Niels Jongs, Robert D. Toto, Jose Luis Gorriz, Fan Fan Hou, John J.V. McMurray, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Bergur V. Stefánsson, Anna Maria Langkilde, David C. Wheeler, Hiddo J.L. Heerspink and DAPA-CKD Trial Committees and Investigators
    JASN September 2021, 32 (9) 2352-2361; DOI: https://doi.org/10.1681/ASN.2021020167
    Add to Selected Citations
  • You have accessRestricted Access
    Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients
    Yoshinari Oka, Masashi Miyazaki, Shigeko Takatsu and Hiroaki Matsuda
    JASN May 2022, ASN.2022030248; DOI: https://doi.org/10.1681/ASN.2022030248
    Add to Selected Citations
  • A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
    Open Access
    A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
    Cynthia Delgado, Mukta Baweja, Deidra C. Crews, Nwamaka D. Eneanya, Crystal A. Gadegbeku, Lesley A. Inker, Mallika L. Mendu, W. Greg Miller, Marva M. Moxey-Mims, Glenda V. Roberts, Wendy L. St. Peter, Curtis Warfield and Neil R. Powe
    JASN December 2021, 32 (12) 2994-3015; DOI: https://doi.org/10.1681/ASN.2021070988
    Add to Selected Citations
  • Open Access
    Enabling Patient Choice: The “Deciding Not to Decide” Option for Older Adults Facing Dialysis Decisions
    Fahad Saeed, Alvin H. Moss, Paul R. Duberstein and Kevin A. Fiscella
    JASN May 2022, 33 (5) 880-882; DOI: https://doi.org/10.1681/ASN.2021081143
    Add to Selected Citations
  • Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
    Open Access
    Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
    Steven Fishbane, Carol A. Pollock, Mohamed El-Shahawy, Elizabeth T. Escudero, Anjay Rastogi, Bui Pham Van, Lars Frison, Mark Houser, Maksym Pola, Dustin J. Little, Nicolas Guzman and Pablo E. Pergola
    JASN April 2022, 33 (4) 850-866; DOI: https://doi.org/10.1681/ASN.2020111638
    Add to Selected Citations
  • Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1
    Open Access
    Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1
    Sanjeev Sethi, Benjamin Madden, Marta Casal Moura, Samih H. Nasr, Nattawat Klomjit, LouAnn Gross, Vivian Negron, M. Cristine Charlesworth, Mariam P. Alexander, Nelson Leung, Ulrich Specks, Fernando C. Fervenza and Mark Haas
    JASN May 2022, 33 (5) 1033-1044; DOI: https://doi.org/10.1681/ASN.2021111488
    Add to Selected Citations
  • Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
    You have accessRestricted Access
    Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
    Michele Provenzano, Maria Jesús Puchades, Carlo Garofalo, Niels Jongs, Luis D’Marco, Michele Andreucci, Luca De Nicola, Jose Luis Gorriz and Hiddo J.L. Heerspink; on behalf of the ROTATE-3 study group
    JASN May 2022, ASN.2022020207; DOI: https://doi.org/10.1681/ASN.2022020207
    Add to Selected Citations
  • Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms
    You have accessRestricted Access
    Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms
    Marine Arnaud, Maud Loiselle, Camille Vaganay, Stéphanie Pons, Emmanuel Letavernier, Jordane Demonchy, Sofiane Fodil, Manal Nouacer, Sandrine Placier, Perrine Frère, Eden Arrii, Julien Lion, Nuala Mooney, Raphael Itzykson, Chakib Djediat, Alexandre Puissant and Lara Zafrani
    JASN June 2022, 33 (6) 1154-1171; DOI: https://doi.org/10.1681/ASN.2021070997
    Add to Selected Citations
  • Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada
    Open Access
    Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada
    Matthew J. Oliver, Doneal Thomas, Shabnam Balamchi, Jane Ip, Kyla Naylor, Stephanie N. Dixon, Eric McArthur, Jeff Kwong, Jeffrey Perl, Mohammad Atiquzzaman, Joel Singer, Angie Yeung, Michelle Hladunewich, Kevin Yau, Amit X. Garg, Jerome A. Leis, Adeera Levin, Mel Krajden and Peter G. Blake
    JASN April 2022, 33 (4) 839-849; DOI: https://doi.org/10.1681/ASN.2021091262
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire